Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 3, 2017

Primary Completion Date

March 4, 2017

Study Completion Date

March 4, 2017

Conditions

Diabetes Mellitus

Interventions

DEVICE

Acetaminophen Challenge (G6 CGM)

Evaluation of acetaminophen effect on CGM glucose sensing

Trial Locations (4)

AMCR, Escondido

William Sansum Diabetes Center, Santa Barbara

Diablo Clinical Research, Walnut Creek

Rainier Clinical Research Center Inc, Renton

All Listed Sponsors

lead

DexCom, Inc.

INDUSTRY

NCT03087877 - Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor | Biotech Hunter | Biotech Hunter